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TPhyllodes tumors (PTs) are rare fibroepithelial neoplasms that account for 0.3% to0.9% of all breast tumors in women.1
Between 1.9% and 50% of reported PTs are considered histologically malignant,2 and in
these forms the risk of distant metastases is high (30%-40%).
We describe the case of a giant pleural metastasis of a PT successfully resected 9 years
after mastectomy for PT.
Clinical Summary
A 67-year-old woman underwent a right mastectomy for a high-grade malignant cystosar-
coma phyllodes of the breast in October 1996. Adjuvant therapy was not administered. The
patient was followed up by clinical outpatient visits and radiography of only the breast.
In 2004 a chest x-ray film, performed because of an increasing dyspnea, showed a large
opacity on the right side. Thoracic computed tomographic scan confirmed the presence of a
giant mass on the right side compressing the superior vena cava and shifting the mediastinum
and heart to the left side (Figure 1).
Diagnosis of PT metastasis was achieved by fine-needle aspiration biopsy.
The patient underwent a right posterolateral thoracotomy. The tumor originated from the
visceral pleura, without chest wall invasion. The upper vena cava and heart were displaced,
but not invaded.
Figure 1. Giant (23 22 cm) right mass, displacing the mediastinumhe Journal of Thoracicto the left side, is evident at the thoracic computed tomography scan.
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Brief CommunicationsA 23  22 cm polylobulated yellow-gray lesion was radically
resected (Figure 2); a limited wedge resection of the upper lobe
was necessary because of dense tumor adhesions.
Histologically, necrotic areas were present within the tumor;
stromal overgrowth and neoplastic cell atypia were also evident.
Immunohistochemically, neoplastic cells were anti-actin and anti-
calponin positive and anti-desmin negative; Ki67 rate was 30%.
The final diagnosis was pleural metastasis of malignant PT.
The postoperative course was complicated by atrial fibrillation,
which was successfully treated with intravenous administration of
amiodarone.
The patient received adjuvant radiation treatment, and she is
alive 11 months after the intervention.
Discussion
A giant (20 cm) thoracic mass is a rare presentation for a
breast cancer pleural metastasis. A radical resection is infre-
Figure 2. Surgical specimen of the polylobulated giant pleural
metastasis of PT of the breast.quent, too.
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ically, PTs represent a spectrum of neoplasms ranging from be-
nign, with a 21% risk of local recurrences, to high-grade malignant
form, with a 25% incidence of distant metastases. Malignant forms
account for 1.9% to 50% of all PTs reported,2 and they are more
frequent in older patients.
Complete tumor resection, by mastectomy when necessary,
represents the treatment of choice of high-grade malignant PT of
the breast. Lymph node dissection plays a very limited role in the
surgical treatment: There is no indication for elective axillary
dissection according to the recent literature.3
High-grade malignant PTs may develop local recurrences and
distant metastases. Local recurrences are a strong predictor of
systemic spread, as Kapiris and colleagues4 demonstrated. In their
series, 11 of 13 patients with distant metastases had a previous
local recurrence. Local recurrence or systemic spread is usually
detected within 3 years of the primary intervention.
Bone, pleura, and lung are the most common distant metastases
sites. To our knowledge there is only 1 report5 about a giant
metastatic cystosarcoma phyllodes to the lung in the literature, and
this is the second case to be successfully resected.
The case we describe has some unique features: a radically
resected high-grade malignant PT metastasis to the pleura with a
giant mass displacing the heart and mediastinum, discovered only
because of dyspnea. Radicality was successfully achieved: No
tumor residual was evident after surgery. Radiation therapy was
proposed with adjuvant intent, and the patient is still alive.
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